Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
Gross Profit Over Time
Above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$373.86M
↑ 104% above average
Average (9y)
$182.82M
Historical baseline
Range
High:$373.86M
Low:$77.35M
CAGR
+19.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $373.86M | +6.5% |
| 2023 | $351.12M | +41.1% |
| 2022 | $248.86M | +24.6% |
| 2021 | $199.74M | +39.3% |
| 2020 | $143.34M | +8.7% |
| 2019 | $131.92M | +23.3% |
| 2018 | $106.98M | +17.8% |
| 2017 | $90.80M | -12.9% |
| 2016 | $104.19M | +34.7% |
| 2015 | $77.35M | - |